High-Fidelity Long-Read Sequencing Market Report 2026

High-Fidelity Long-Read Sequencing Market Overview

• High-Fidelity Long-Read Sequencing market size has reached to $1.53 billion in 2025 • Expected to grow to $4.22 billion in 2030 at a compound annual growth rate (CAGR) of 22.5% • Growth Driver: Rising Rare Disease Prevalence Driving The Market Growth Due To Increasing Demand For Comprehensive Genomic Analysis • Market Trend: Advancements In High-Accuracy Long-Read Sequencing Through Hybrid-Capture Enrichment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under High-Fidelity Long-Read Sequencing Market?

High-fidelity long-read sequencing is an advanced DNA Sequencing technology that generates long, highly accurate nucleotide reads by repeatedly sequencing single DNA molecules to produce consensus sequences. It combines the benefits of long-read length with low error rates, enabling precise detection of genetic variants, structural rearrangements, and complex genomic regions. It helps to achieve high-resolution, accurate genome analysis for research, diagnostics, and precision medicine. The main product types of high-fidelity (HiFi) long-read sequencing include instruments, consumables, and software. Instruments refer to sequencing platforms designed to generate highly accurate long-read DNA or RNA sequences for advanced genomic analysis. These products use sequencing technologies such as single-molecule real-time sequencing (SMRT), nanopore sequencing, and other sequencing technologies. They are applied across areas including clinical diagnostics, Genomics research, oncology, rare disease detection, agriculture and animal research, and other applications, and are used by end users including academic and research institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and other end users.

What Is The High-Fidelity Long-Read Sequencing Market Growth Forecast?

The high-fidelity long-read sequencing market size is expected to see exponential growth in the next few years. It will grow to $4.22 billion in 2030 at a compound annual growth rate (CAGR) of 22.5%. The growth in the forecast period can be attributed to growing use of precision medicine approaches, rising investments in genomics-based drug discovery, expansion of rare disease research, increasing clinical adoption of long-read sequencing, advancements in sequencing cost efficiency. Major trends in the forecast period include increasing adoption of long-read sequencing in clinical diagnostics, rising demand for high-accuracy variant detection, growing use of de novo genome assembly techniques, expansion of epigenetic and transcriptomic analysis applications, enhanced integration of advanced bioinformatics tools.

Global High-Fidelity Long-Read Sequencing Market Segmentation

1) By Product Type: Instruments; Consumables; Software 2) By Sequencing Technology: Single-Molecule Real-Time Sequencing; Nanopore Sequencing; Other Sequencing Technologies 3) By Application: Clinical Diagnostics; Genomics Research; Oncology; Rare Disease Detection; Agriculture And Animal Research; Other Applications 4) By End-User: Academic And Research Institutes; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Users Subsegments: 1) By Instruments: Sequencers; Library Preparation Systems; Sample Preparation Instruments; Data Collection Devices; Quality Control Instruments 2) By Consumables: Sequencing Kits; Flow Cells; Reagents; Pipette Tips; Sample Tubes 3) By Software: Data Analysis Software; Visualization Software; Sequence Alignment Software; Genome Assembly Software; Quality Assessment Software

What Is The Driver Of The High-Fidelity Long-Read Sequencing Market?

The rising prevalence of rare diseases is expected to propel the growth of the HiFi long-read sequencing market going forward. Rare diseases are disorders that impact a limited number of people, usually with complex symptoms and limited treatment options. Rare diseases are increasing due to advances in genetic sequencing and diagnostic technologies, which are enabling earlier and more accurate identification of previously undiagnosed or misclassified conditions. HiFi long-read sequencing helps address rare diseases by enabling highly accurate, comprehensive detection of complex genetic variants that are often missed by short-read sequencing, leading to faster and more precise diagnoses. For instance, in July 2023, according to the Department of Health & Social Care, a UK-based government department, it is estimated that more than 7,000 rare diseases exist, with new conditions consistently being discovered as research progresses. Approximately 80% of these rare diseases are known to have a genetic basis. Therefore, the rising prevalence of rare diseases is driving the growth of the HiFi long-read sequencing market.

Key Players In The Global High-Fidelity Long-Read Sequencing Market

Major companies operating in the high-fidelity long-read sequencing market are Azenta Inc., BGI Genomics Co. Ltd., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Inc., MGI Tech Co. Ltd., Discovery Life Sciences Inc., Eurofins Genomics LLC, CD Genomics, BaseClear B.V., Psomagen Inc., Health in Code S.L., Creative Biogene Inc., Nucleome Informatics Private Limited, Genevia Technologies Oy, JS Link Co. Ltd., SeqCenter LLC, Theragen Bio Co. Ltd.

Global High-Fidelity Long-Read Sequencing Market Trends and Insights

Major companies operating in the HiFi long-read sequencing market are focusing on developing innovative solutions, such as hybrid-capture target enrichment, to enhance sequencing accuracy, increase coverage of complex genomic regions, and accelerate the detection of structural variants for advanced research and clinical applications. Hybrid-capture target enrichment refers to a genomic sequencing technique that selectively isolates specific regions of DNA or RNA from a sample using complementary probes, allowing for focused, high-accuracy sequencing of target regions while reducing sequencing of non-relevant regions. For instance, in July 2025, QIAGEN N.V., a Netherlands-based biotechnology company, launched QIAseq xHYB Long Read Panels to expand its next-generation sequencing (NGS) offerings. It uses hybrid-capture enrichment to enable precise long-read sequencing of complex genomic regions like repeats and structural variants, overcoming short-read limitations. They offer superior uniformity, specificity, and complete coverage for applications in cancer profiling, HLA typing, and haplotype phasing, with flexible fixed or custom formats and integrated workflows from DNA prep to bioinformatics analysis. Benefits include streamlined efficiency and deeper insights for precision medicine.

What Are Latest Mergers And Acquisitions In The High-Fidelity Long-Read Sequencing Market?

In November 2025, Agilent Technologies Inc., a US-based life sciences company, partnered with Pacific Biosciences of California Inc. to enhance genomic sequencing solutions and speed up research applications. This partnership aims to promote the adoption of PacBio's HiFi long-read sequencing in clinical diagnostic testing by integrating Agilent's target enrichment panels for efficient detection of complex genomic variants, thereby improving diagnostic yield and expanding global laboratory access. Pacific Biosciences of California Inc. is a US-based company that provides HiFi long-read sequencing technologies for high-accuracy genomic analysis and research applications.

Regional Insights

North America was the largest region in the HiFi long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the High-Fidelity Long-Read Sequencing Market?

The high-fidelity long-read sequencing market consists of revenues earned by entities by providing services such as sample preparation and library construction, de novo genome assembly, variant detection and phasing, and epigenetic and transcriptomic analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The high-fidelity long-read sequencing market also includes sales of sequencing consumables and reagents, sample preparation and library construction kits, flow cells and chips, quality control materials, and associated sequencing hardware and software products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the High-Fidelity Long-Read Sequencing Market Report 2026?

The high-fidelity long-read sequencing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the high-fidelity long-read sequencing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.